Snapshots

Search

Search managers or tickers

RXRX Recursion Pharmaceuticals In

held by 1 manager in Q4 2023 Latest
Manager% of their portfolioHeldActivityValueShares
Stanley Druckenmiller Duquesne Family Office 0.29% 2.5 yr $9M 906,767